30803263
2019 May
In this review, we address the potential of human-induced pluripotent stem cell-based hepatobiliary differentiation technology as a means to study human liver development and cell fate determination, and to model liver diseases in an effort to develop a new human-relevant preclinical platform for drug development.
Human-induced pluripotent stem cell; YAP; hepatobiliary development; liver disease.
